BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 19509614)

  • 1. The relative roles of bacteria and host inflammatory cells in SIgA degradation.
    Diebel LN; Liberati DM; Diglio CA
    J Trauma; 2009 Jun; 66(6):1556-62; discussion 1562-3. PubMed ID: 19509614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage of SIgA by gram negative respiratory pathogens enhance neutrophil inflammatory potential.
    Diebel LN; Liberati DM; Amin PB; Diglio CA
    J Trauma; 2009 May; 66(5):1336-42; discussion 1342. PubMed ID: 19430236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence of immunoglobulin isotype exposure modulates inflammatory response to bacteria and lipopolysaccharide in vitro.
    Diebel LN; Amin PB; Liberati DM
    Surg Infect (Larchmt); 2010 Apr; 11(2):145-50. PubMed ID: 20235878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory immunoglobulin a blunts gut-mediated priming of neutrophils in vitro.
    Amin PB; Diebel LN; Liberati DM
    J Trauma; 2008 Jun; 64(6):1437-42. PubMed ID: 18545106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin A protease is a virulence factor for gram-negative pneumonia.
    Diebel LN; Liberati DM; Baylor AE; Brown WJ; Devlin J
    Surgery; 2004 Oct; 136(4):937-43. PubMed ID: 15467681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of human monocytes via their sIgA receptors.
    Padeh S; Jaffe CL; Passwell JH
    Immunology; 1991 Feb; 72(2):188-93. PubMed ID: 2016119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of secretory immunoglobulin A and immunoglobulin G in host defense in an in vitro pneumonia model.
    Diebel LN; Liberati DM; White MT; Diglio CA; Brown WJ
    Am J Surg; 2006 Mar; 191(3):386-90. PubMed ID: 16490552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits.
    Boullier S; Tanguy M; Kadaoui KA; Caubet C; Sansonetti P; Corthésy B; Phalipon A
    J Immunol; 2009 Nov; 183(9):5879-85. PubMed ID: 19828639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal barrier mechanisms. Interplay between secretory IgA (SIgA), IgG and mucins on the surface properties and association of salmonellae with intestine and granulocytes.
    Magnusson KE; Stjernström I
    Immunology; 1982 Feb; 45(2):239-48. PubMed ID: 7037617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of anti-Pseudomonas aeruginosa specific secretory IgA antibodies in tears of patients with Pseudomonas aeruginosa keratitis].
    Nakashima M; Inada N; Kato H; Shoji J; Sawa M
    Nippon Ganka Gakkai Zasshi; 2013 Dec; 117(12):996-1003. PubMed ID: 24516981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a secretory IgA receptor on breast-milk macrophages: evidence for specific activation via these receptors.
    Robinson G; Volovitz B; Passwell JH
    Pediatr Res; 1991 May; 29(5):429-34. PubMed ID: 1716755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin A with protease activity secreted in human milk activates PAR-2 receptors, of intestinal epithelial cells HT-29, and promotes beta-defensin-2 expression.
    Barrera GJ; Portillo R; Mijares A; Rocafull MA; del Castillo JR; Thomas LE
    Immunol Lett; 2009 Mar; 123(1):52-9. PubMed ID: 19428552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of phagocytosis, surface hydrophobicity and charge of Salmonella typhimurium 395 MR10 by reaction with secretory IgA (SIgA).
    Magnusson KE; Stendahl O; Stjernström I; Edebo L
    Immunology; 1979 Mar; 36(3):439-47. PubMed ID: 374252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin a modulates inflammatory responses in an in vitro model of pneumonia.
    Diebel LN; Liberati DM; Diglio CA; Brown WJ
    J Trauma; 2005 Nov; 59(5):1099-106. PubMed ID: 16385286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression analysis in human polymorphonuclear leukocytes stimulated by LPSs from nosocomial opportunistic pathogens.
    Ubagai T; Nakano R; Nakano A; Kamoshida G; Ono Y
    Innate Immun; 2015 Nov; 21(8):802-12. PubMed ID: 26376669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggregated human colostral sIgA stimulates delayed, non-complement-dependent, NBT reduction by human neutrophils.
    Bullock WW; Wang YZ; Gabler WL; Creamer HR
    Inflammation; 1989 Feb; 13(1):67-78. PubMed ID: 2921084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of lactotransferrin in the molecular mechanisms of antibacterial defense].
    Spik G; Montreuil J
    Bull Eur Physiopathol Respir; 1983; 19(2):123-30. PubMed ID: 6347280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minocycline--an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii.
    Bishburg E; Bishburg K
    Int J Antimicrob Agents; 2009 Nov; 34(5):395-401. PubMed ID: 19665876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal immunity: induction, dissemination, and effector functions.
    Brandtzaeg P
    Scand J Immunol; 2009 Dec; 70(6):505-15. PubMed ID: 19906191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altering and assessing persistence of genetically modified E. coli MG1655 in the large bowel.
    Barbas AS; Lesher AP; Thomas AD; Wyse A; Devalapalli AP; Lee YH; Tan HE; Orndorff PE; Bollinger RR; Parker W
    Exp Biol Med (Maywood); 2009 Oct; 234(10):1174-85. PubMed ID: 19596821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.